Literature DB >> 28138617

Conversion therapy for stage IV gastric cancer-the present and future.

Kazuya Yamaguchi1, Kazuhiro Yoshida1, Yoshihiro Tanaka1, Nobuhisa Matsuhashi1, Toshiyuki Tanahashi1, Takao Takahashi1.   

Abstract

Entities:  

Year:  2016        PMID： 28138617      PMCID： PMC5244716          DOI： 10.21037/tgh.2016.05.12

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  24 in total

Review 1.  Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?

Authors:  Yasuhiro Kodera; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

2.  Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer.

Authors:  Y Yamada; K Higuchi; K Nishikawa; M Gotoh; N Fuse; N Sugimoto; T Nishina; K Amagai; K Chin; Y Niwa; A Tsuji; H Imamura; M Tsuda; H Yasui; H Fujii; K Yamaguchi; H Yasui; S Hironaka; K Shimada; H Miwa; C Hamada; I Hyodo
Journal:  Ann Oncol       Date:  2014-10-14       Impact factor: 32.976

3.  Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer.

Authors:  Seiji Satoh; Hiroshi Okabe; Satoshi Teramukai; Suguru Hasegawa; Nobuhiro Ozaki; Shugo Ueda; Ayumi Tsuji; Satomi Sakabayashi; Masanori Fukushima; Yoshiharu Sakai
Journal:  Gastric Cancer       Date:  2011-06-11       Impact factor: 7.370

Review 4.  The roles of surgical oncologists in the new era: minimally invasive surgery for early gastric cancer and adjuvant surgery for metastatic gastric cancer.

Authors:  Kazuhiro Yoshida; Kazuya Yamaguchi; Naoki Okumura; Shinji Osada; Takao Takahashi; Yoshihiro Tanaka; Kazuaki Tanabe; Takahisa Suzuki
Journal:  Pathobiology       Date:  2011-11-18       Impact factor: 4.342

5.  Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination.

Authors:  Seiji Satoh; Suguru Hasegawa; Nobuhiro Ozaki; Hiroshi Okabe; Go Watanabe; Satoshi Nagayama; Masanori Fukushima; Arimichi Takabayashi; Yoshiharu Sakai
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

6.  A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002.

Authors:  Hiroshi Katayama; Seiji Ito; Takeshi Sano; Daisuke Takahari; Junki Mizusawa; Narikazu Boku; Akira Tsuburaya; Masanori Terashima; Mitsuru Sasako
Journal:  Jpn J Clin Oncol       Date:  2012-04-23       Impact factor: 3.019

7.  Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases.

Authors:  Dong-Seok Han; Yun-Suhk Suh; Seong-Ho Kong; Hyuk-Joon Lee; Seock-Ah Im; Yung-Jue Bang; Woo-Ho Kim; Han-Kwang Yang
Journal:  J Surg Oncol       Date:  2012-10-22       Impact factor: 3.454

8.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

9.  Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).

Authors:  W Koizumi; H Takiuchi; Y Yamada; N Boku; N Fuse; K Muro; Y Komatsu; A Tsuburaya
Journal:  Ann Oncol       Date:  2009-10-29       Impact factor: 32.976

10.  Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.

Authors:  A Tsuburaya; J Mizusawa; Y Tanaka; N Fukushima; A Nashimoto; M Sasako
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939
View more
  2 in total

1.  Minimally invasive surgery is feasible after preoperative chemotherapy for stage IV gastric cancer.

Authors:  Kazuyoshi Yamamoto; Takeshi Omori; Hisashi Hara; Naoki Shinno; Keijiro Sugimura; Hiroshi Miyata; Hidenori Takahashi; Yoshiyuki Fujiwara; Masayuki Ohue; Masahiko Yano
Journal:  Ann Gastroenterol Surg       Date:  2020-05-29

2.  Long-term Results of Conversion Therapy for Initially Unresectable Gastric Cancer: Analysis of 122 Patients at the National Cancer Center in China.

Authors:  Tongbo Wang; Nianchang Wang; Hu Ren; Hong Zhou; Aiping Zhou; Jing Jin; Yingtai Chen; Dongbing Zhao
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.